HS
Hartaj Singh Oppenheimer Latest Price Targets & Analyst Ratings
# | Stock | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|
1 |
1
Sarepta Therapeutics
SRPT
$1.96B
| $18.71 | $37 |
98%
upside
| Outperform | 1 month ago |
|
2 |
2
Regeneron Pharmaceuticals
REGN
$60.8B
| $573.38 | $900 |
57%
upside
| Outperform | 4 months ago |
|
3 |
3
Gilead Sciences
GILD
$143B
| $115.05 | $125 |
9%
upside
| Outperform | 4 months ago |
|
4 |
4
Astria Therapeutics
ATXS
$424M
| $7.52 | $28 |
272%
upside
| Outperform | 9 months ago |
|
5 |
5
United Therapeutics
UTHR
$18.1B
| $400.52 | $600 |
50%
upside
| Outperform | 10 months ago |
|
6 |
CLLS
6
Cellectis
CLLS
$269M
| $2.68 | $10 |
273%
upside
| Outperform | 1 year ago |
|